Abstract
Some colorectal cancer (CRC) outcomes are partially associated with genetics, and different studies have proposed several genetic variants as predictors. However, analysis of their performance in other populations is limited. Thus, our objectives were to assess their use in our cohort and to find additional genetic variants associated with CRC outcomes. We found that some of the genetic variants proposed as predictors could be used in our cohort, although the addition of clinical data improved the performance. In addition, we found additional genetic variants that could be useful to predict the CRC manifestations in our population. Our findings will help to refine the use of genetic polymorphisms to predict CRC outcomes in our population, and we expect that our findings could be useful for other populations.